Taligen Therapeutics, Inc.

Greenwood Village, CO 80111

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $1.02MM
First Award Date 04/15/05
Most Recent Award Date 08/01/06

Key Personnel

Last Name Name Awards Contact
Emlen Woodruff Emlen 5

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 08/01/06 - 07/31/07

DESCRIPTION (provided by applicant): Asthma is a chronic, potentially debilitating disease caused by inflammation of the small airways, leading to the clinical symptoms of wheezing and shortness of breath. It is now estimated that asthma affects 20-25 million individuals in the United States and many more worldwide. The prevalence of the diseas...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/06 - 04/30/08

DESCRIPTION (provided by applicant): Age-related macular degeneration (AMD) is the leading cause of blindness for Americans 60 years of age and older. It is estimated that the prevalence of AMD in the US is as high as 9 million, with 1.8 million individuals already suffering severe loss of vision from advanced AMD. As the population ages, the pr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/05 - 08/31/06

DESCRIPTION (provided by applicant): Chronic Glomerulonephritis (chronic GN) is one of the most common forms of chronic renal disease, and is the third leading cause of renal failure in the US. While the classification of GN is complex and the etiology of many forms of chronic GN remains unknown, data suggest that antibody or immune complex-med...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-04-27
Budget: 08/15/05 - 07/31/06

DESCRIPTION (provided by applicant): Asthma is a chronic, potentially debilitating disease caused by inflammation of the small airways, leading to the clinical symptoms of wheezing and shortness of breath. It is now estimated that asthma affects 20-25 million individuals in the United States and many more worldwide. The prevalence of the diseas...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/15/05 - 09/30/05

DESCRIPTION (provided by applicant): Rheumatoid Arthritis (RA) affects 1-2% of the world's population, including an estimated 2.5 million people in the US. Although therapies targeted at tumor necrosis factor alpha (TNF) have been highly successful, they are ineffective in up to 50% of individuals. RA remains a debilitating and life-long afflict...